Medicines and Related Substances Control Act, 1965 (Act No. 101 of 1965)NoticesNotification of Retention Fee PaymentNotice No. R. 164 of 2021 |
Notice No. R. 164
2 March 2021
GG 44215
Department of Health
Payment is required in respect of retention of the registration of a medicine, the registration of which has been approved by the Authority in terms of Section 15(3).
Since the retention fees have not been received for the products listed below, the registration may be cancelled in terms of the Section 16(4).
The Applicant has until 12 March 2021 to notify SAHPRA of their intention to retain the registration of the products and the outstanding retention fees should be paid by no later than the 19th of March 2021.
Communication should be emailed to [email protected].
Chief Executive Officer
Applicant Name |
A G Cohen |
Healthcare Industries |
Isren Laboratories CC |
Jav Webb |
Lyttleton Pharmacy |
Mediscience (Pty) Ltd |
National Druggists |
Caps Pharmaceuticals SA (Pty) Ltd |
|
|
E0986 |
270453 |
T0231 |
280111 |
290642 |
270009 |
270415 |
270022 |
V0227 |
|
|
|
|
Y0362 |
|
270012 |
290297 |
280274 |
V0228 |
|
|
|
|
Y0363 |
|
270016 |
290299 |
280304 |
V0229 |
|
|
|
|
Y0364 |
|
270017 |
|
280305 |
V0293 |
|
|
|
|
Y0365 |
|
270018 |
|
280316 |
V0294 |
|
|
|
|
Y0366 |
|
310669 |
|
280565 |
X0064 |
|
|
|
|
Y0367 |
|
|
|
280566 |
X0065 |
|
|
|
|
|
|
|
|
300416 |
X0066 |
|
|
|
|
|
|
|
|
300417 |
X0243 |
|
|
|
|
|
|
|
|
B0020 |
Z0008 |
|
|
|
|
|
|
|
|
F0027 |
|
|
|
|
|
|
|
|
|
V0058 |
|
|
|
|
|
|
|
|
|
V0059 |
|
|
|
|
|
|
|
|
|
V0060 |
|
|
|
|
|
|
|
|
|
V0061 |
|
|
|
|
|
|
|
|
|
V0070 |
|
|
|
|
|
|
|
|
|
V0071 |
|
|
|
|
|
|
|
|
|
V0072 |
|
|
|
|
|
|
|
|
|
V0112 |
|
|
|
|
|
|
|
|
|
V0113 |
|
|
|
|
|
|
|
|
|
V0114 |
|
|
|
|
|
|
|
|
|
V0115 |
|
|
|
|
|
|
|
|
|
V0185 |
|
|
|
|
|
|
|
|
|
V0186 |
|
|
|
|
|
|
|
|
|
V0187 |
|
|
|
|
|
|
|
|
|
V0188 |
|
|
|
|
|
|
|
|
|
V0189 |
|
|
|
|
|
|
|
|
|
V0225 |
|
|
|
|
|
|
|
|
|
V0226 |
|